UroGen Pharma Ltd.
URGN
$19.69
-$0.095-0.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -34.89% | 19.41% | 72.80% | 69.30% | 409.67% |
| Total Receivables | 12.83% | 38.71% | 31.46% | 77.49% | 12.32% |
| Inventory | -4.22% | 4.79% | 62.65% | 51.82% | 49.20% |
| Prepaid Expenses | -1.25% | 23.75% | -13.97% | -12.38% | -4.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 31.15% | 30.74% | 31.06% | 31.33% | 1.10% |
| Total Current Assets | -29.43% | 20.54% | 63.21% | 62.03% | 242.99% |
|
|
|||||
| Total Current Assets | -29.43% | 20.54% | 63.21% | 62.03% | 242.99% |
| Net Property, Plant & Equipment | 240.93% | 167.79% | 60.55% | -39.15% | -39.34% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.33% | -58.69% | -66.20% | -76.04% | -72.11% |
| Total Assets | -25.95% | 23.45% | 60.23% | 55.94% | 195.56% |
|
|
|||||
| Total Accounts Payable | 63.09% | 132.74% | 67.81% | 37.49% | 78.51% |
| Total Accrued Expenses | 30.32% | 34.58% | 29.91% | 27.28% | 20.69% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 94.47% | 81.51% | 86.81% | -3.85% | -12.53% |
| Total Finance Division Other Current Liabilities | 20.11% | 36.35% | 111.05% | 20.52% | 3.41% |
| Total Other Current Liabilities | 20.11% | 36.35% | 111.05% | 20.52% | 3.41% |
| Total Current Liabilities | 38.94% | 59.45% | 47.22% | 27.14% | 27.86% |
|
|
|||||
| Total Current Liabilities | 38.94% | 59.45% | 47.22% | 27.14% | 27.86% |
| Long-Term Debt | 25.25% | 25.12% | 23.52% | 23.54% | -0.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 703.06% | 346.00% | 95.85% | -79.34% | -64.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.02% | 9.46% | 10.86% | 10.36% | 10.74% |
| Total Liabilities | 20.10% | 22.17% | 20.94% | 17.32% | 7.59% |
|
|
|||||
| Common Stock & APIC | 4.03% | 19.66% | 29.84% | 29.85% | 57.22% |
| Retained Earnings | -20.80% | -19.45% | -18.68% | -17.66% | -17.99% |
| Treasury Stock & Other | 119.35% | 137.84% | 366.67% | 276.12% | 79.87% |
| Total Common Equity | -408.03% | -15.76% | 86.50% | 160.76% | 121.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -408.03% | -15.76% | 86.50% | 160.76% | 121.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -408.03% | -15.76% | 86.50% | 160.76% | 121.90% |
|
|
|||||